N-methoxy-N-acylnitrenium ions: Application to the formal synthesis of (-)-TAN1251A

Organic Letters

Volumn 3, Issue 7, 2001, Pages 1053-1056

  Wardrop, Duncan J ^a   Basak, Arindrajit ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROCYCLIC COMPOUND; ION; MUSCARINIC RECEPTOR BLOCKING AGENT; SPIRO COMPOUND; TAN1251A; TYROSINE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; SYNTHESIS;

AZA COMPOUNDS; CYCLIZATION; IONS; MOLECULAR STRUCTURE; MUSCARINIC ANTAGONISTS; SPIRO COMPOUNDS; TYROSINE;

EID: 0035810366     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol015626o     Document Type: Article

References (43)

1. Gassman, P. G. Acc. Chem. Res. 1970, 3, 26-33.
2. (a) Garner, R. C.; Martin, C. N.; Clayson, D. B. In Chemical Carcinogens, 2nd ed.; Searle, C. E., Ed.; ACS Monograph 182; American Chemical Society: Washington, DC, 1984; Vol. 1, pp 175-276.
3. (b) Kennedy, S. A.; Novak, M.; Kolb, B. A. J. Am. Chem. Soc. 1997, 119, 7654-7664.
4. (c) Novak, M.; Xu, L.; Wolf, R. A. J. Am. Chem. Soc. 1998, 120, 1643-1644.
5. (d) McClelland, R. A.; Ahmad, A., Dicks, A. P.; Licence, V. E. J. Am. Chem. Soc. 1999, 121, 3303-3310.
6. (a) Abramovitch, R. A.; Jeyaraman, R. In Azides and Nitrenes: Reacting and Utility; Striven, E. F. V., Ed.; Academic Press: Orlando, FL, 1984; pp 297-357.
7. (b) Simonova, T. P.; Nefedov, V. D.; Toropova, M. A.; Kirillov, N. F. Russ. Chem. Rev. 1992, 61, 584-599.
8. (c) McClelland, R. A. Tetrahedron 1996, 52, 6823-6858.
9. (a) Glover, S. A.; Goosen, A.; McCleland, C. W.; Schoonraad, J. L. J. Chem. Soc., Perkin Trans, 1 1984, 2255-2260.
10. (b) Kikugawa, Y.; Kawase, M. J. Am. Chem. Soc. 1984, 106, 5728-5729
11. (c) Kawase, M.; Kitamura T.; Kikugawa, Y. J. Org. Chem. 1989, 54, 3394-3403.
12. (d) Glover, S. A.; Scott, A. P. Tetrahedron 1989, 45, 1763-1776.
13. (e) Kikugawa, Y.; Kawase, M. Chem. Lett. 1990, 581-582.
14. (f) Kikugawa, Y.; Shimada, M.; Matsumoto, K. Heterocycles 1994, 37, 293-301.
15. For recent reviews of hypervalent iodine(III) reagents, see: (a) Stang, P. J.; Zhdankin, V. V. Chem. Rev. 1996, 96, 1123-1178.
16. (b) Varvogolis, A. Hypervalent Iodine in Organic Synthesis; Academic Press: San Diego, 1997.
17. (c) Kitamura, T.; Fujiwara, Y. Org. Prep. Proc. Int. 1997, 29, 409-458.
18. Kawase, M.; Miyake, Y.; Sakamoto, T.; Shimada, M.; Kikugawa, Y. Tetrahedron 1989, 45, 1653-1660.
19. Fleming, I.; Moses, R. C.; Tercel, M.; Ziv, J. J. Chem. Soc., Perkin Trans. 1 1991, 617-626.
20. Romero, A. G.; Darlington, W. H.; McMillan, M. W. J. Org. Chem. 1997, 62, 6582-6587.
21. While this work was in progress, Ciufolini and Sorenson independently reported complementary methods for preparing spirocyclic pyrrolidinones involving the oxidation of phenolic oxazolines, and amines, respectively. These transformations involve aryl oxidation and subsequent trapping rather than the formation of N-acylnitrenium ions: (a) Braun, N. A.; Ousmer, M.; Bray, J. D.; Bouchu, D.; Peters, K.; Peters, E. M.; Ciufolini, M. A. J. Org. Chem. 2000, 65, 4397-4408.
22. (b) Scheffler, G.; Seike, H.; Sorenson, E. J. Angew. Chem., Int. Ed. 2000, 39, 4593-4596.
23. Shirafuji, H.; Tsubotani, S.; Ishimaru, T.; Harada, S. PCT Int. Appl. 1991, WO 91 13,887; Chem. Abstr. 1992, 116, 39780t.
24. Shirafuji, H.; Tsubotani, S.; Ishimaru, T.; Harada, S. PCT Int. Appl. 1991, WO 91 13,887; Chem. Abstr. 1992, 116, 39780t.
25. Sakamoto, K.; Tsujii, E.; Abe, F.; Nakanishi, T.; Yamashita, M.; Shigematsu, N.; Izumi, S.; Okuhara, M. J. Antibiot. 1996, 49, 37-44.
26. Blackman, A. J.; Li, C.; Hockless, D. C. R.; Skelton, B. W.; White, A. H. Tetrahedron 1993, 49, 8645-8656.
27. Although unprecedented in Nature, 1,4-diazabicyclo[3.2.1]octanes have been the subject of previous synthetic studies: Hirschfield, A.; Taub, W. Tetrahedron 1972, 28, 1275-1287. Strum, P. A.; Cory, M.; Henry, D. W.; Ziegler, J. B.; McCall, J. W. J. Med. Chem. 1977, 20, 1333-1337.
28. Although unprecedented in Nature, 1,4-diazabicyclo[3.2.1]octanes have been the subject of previous synthetic studies: Hirschfield, A.; Taub, W. Tetrahedron 1972, 28, 1275-1287. Strum, P. A.; Cory, M.; Henry, D. W.; Ziegler, J. B.; McCall, J. W. J. Med. Chem. 1977, 20, 1333-1337.
29. Widzowski, D.; Helander, H. F.; Wu, E. S. C. Drug Discovery Today 1997, 2, 341-350.
30. Nagumo, S.; Nishida, A.; Yamazaki, C.; Murashige, K.; Kawahara, N. Tetrahedron Lett. 1998, 39, 4493-4496.
31. Snider, B. B.; Lin, H. Org. Lett. 2000, 2, 643-646.
32. 8
33. Determann, H.; Zipp, O.; Wieland, T. Liebigs Ann. Chem. 1962, 651, 172-184.
34. König, W.; Geiger, R. Chem. Ber. 1970, 103, 788-798.
35. 2 alone led to lower yields of 10.
36. 9a work, was not observed with our spriocyclic system.
37. For other examples of the reduction of N-methoxyamides to N-methoxyamines, see: (a) Godjoian, G.; Singaram, B. Tetrahedron Lett. 1997, 38, 1717-1720.
38. (b) Uneme, H.; Mitsudera, H.; Yamada, J.; Kamikado, T.; Kono, Y.; Manabe, Y.; Numata, M. Biosci., Biotechnol., Biochem. 1992, 56, 1293-1299.
39. Iida, H.; Watanabe, Y.; Kibayashi, C. Tetrahedron Lett. 1986, 27, 5513-5514.
40. Shioiri, T.; Ninomiya, K.; Yamada, S. J. Am. Chem. Soc. 1972, 94, 6203-6205.
41. For a discussion of the peptide coupling of secondary amines, see: Humphrey, J. M.; Chamberlin, A. R. Chem. Rev. 1997, 97, 2243-2266.
42. Prepared by the alkylation of p-hydroxybenzaldehyde with 1-bromo-3-methyl-2-butene: Chari, V. M.; Aurnhammer, G.; Wagner, H. Tetrahedron Lett. 1970, 11, 3079-3082.
43. 9 -8.1° (c 0.42, MeOH)).